Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.

Children with Down syndrome (DS) up to the age of 4 years are at a 150-fold excess risk of developing myeloid leukemia (ML-DS). Approximately 4%-5% of newborns with DS develop transient myeloproliferative disorder (TMD). Blast cell structure and immunophenotype are similar in TMD and ML-DS. A mutati...

Detaylı Bibliyografya
Asıl Yazarlar:	Alford, K, Reinhardt, K, Garnett, C, Norton, A, Böhmer, K, von Neuhoff, C, Kolenova, A, Marchi, E, Klusmann, J, Roberts, I, Hasle, H, Reinhardt, D, Vyas, P
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2011

Benzer Materyaller

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
Yazar:: Reinhardt, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
Yazar:: Reinhardt, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
Yazar:: Maroz, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
Yazar:: Maroz, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
Yazar:: Garnett, C, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
Yazar:: Roy, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
Yazar:: Norton, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
Yazar:: Hasle, H, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
Yazar:: Carpenter, E, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
Yazar:: Vyas, P, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
Yazar:: Marius Flasinski, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Transient myeloproliferative disorder in Down′s syndrome
Yazar:: Vinayak Y Kshirsagar, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
Yazar:: Labuhn, M, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
Yazar:: Hellebostad, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
Yazar:: Tunstall-Pedoe, O, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
Yazar:: Heald, B, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

DNMT3A mutations are rare in childhood acute myeloid leukemia
Yazar:: Felicitas Thol, ve diğerleri
Baskı/Yayın Bilgisi: (2011-08-01)

Transient Myeloproliferative Disorder and Down Syndrome Is there a link?
Yazar:: Zenaida S. Reyes, ve diğerleri
Baskı/Yayın Bilgisi: (2012-11-01)

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS
Yazar:: Eline J.M. Bertrums, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Acute leukemias in children with Down syndrome.
Yazar:: Zwaan, C, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

How do Gata1 and cohesin gene mutations contribute to the development of myeloid leukaemia?
Yazar:: Garnett, C
Baskı/Yayın Bilgisi: (2020)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
Yazar:: Cruz Hernandez, D, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
Yazar:: Roberts, I, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
Yazar:: Halsey, C, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Acute leukemias in children with Down syndrome.
Yazar:: Zwaan, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Low frequency of type-I and type-II aberrations in myeloid leukemia of Down syndrome, underscoring the unique entity of this disease
Yazar:: Marjolein Blink, ve diğerleri
Baskı/Yayın Bilgisi: (2012-04-01)

GATA1 mutational analysis in chronic myeloid leukaemia.
Yazar:: Halsey, C, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia
Yazar:: Anand A. Patel, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Natural history of GATA-1 mutations in Down syndrome.
Yazar:: Ahmed, M, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Myeloid pre-leukemia and leukemia of Down syndrome
Yazar:: Cruz Hernandez, D, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Natural history of GATA1 mutations in Down syndrome.
Yazar:: Ahmed, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
Yazar:: Labuhn, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study
Yazar:: Marjolein Blink, ve diğerleri
Baskı/Yayın Bilgisi: (2014-02-01)

Impact of mutant haemopoietic transcription factor GATA1s on haemopoiesis
Yazar:: Vyas, P, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome
Yazar:: Tunstall, O, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Loss of DEP-1 (Ptprj) promotes myeloproliferative disease in FLT3-ITD acute myeloid leukemia
Yazar:: Anne Kresinsky, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

GATA2 mutations and overexpression in pediatric acute myeloid leukemia
Yazar:: Zhenzhen Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia
Yazar:: Tim Kong, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Myeloproliferative Neoplasm or Reactive Process? A Rare Case of Acute Myeloid Leukemia and Transient Posttreatment Megakaryocytic Hyperplasia with JAK-2 Mutation
Yazar:: Steven Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.
Yazar:: Vyas, P, ve diğerleri
Baskı/Yayın Bilgisi: (2006)